EP1023076A4 - Utilisation du gene suppresseur de tumeur p-ten dans le diagnostic et le traitement de cancer - Google Patents
Utilisation du gene suppresseur de tumeur p-ten dans le diagnostic et le traitement de cancerInfo
- Publication number
- EP1023076A4 EP1023076A4 EP98908523A EP98908523A EP1023076A4 EP 1023076 A4 EP1023076 A4 EP 1023076A4 EP 98908523 A EP98908523 A EP 98908523A EP 98908523 A EP98908523 A EP 98908523A EP 1023076 A4 EP1023076 A4 EP 1023076A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- diagnosis
- cancer
- treatment
- suppressor gene
- suppressor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 108700025695 Suppressor Genes Proteins 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3694397P | 1997-02-07 | 1997-02-07 | |
US36943P | 1997-02-07 | ||
PCT/US1998/002615 WO1998034624A1 (fr) | 1997-02-07 | 1998-02-06 | Utilisation du gene suppresseur de tumeur p-ten dans le diagnostic et le traitement de cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1023076A1 EP1023076A1 (fr) | 2000-08-02 |
EP1023076A4 true EP1023076A4 (fr) | 2001-11-21 |
Family
ID=21891553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98908523A Withdrawn EP1023076A4 (fr) | 1997-02-07 | 1998-02-06 | Utilisation du gene suppresseur de tumeur p-ten dans le diagnostic et le traitement de cancer |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1023076A4 (fr) |
AU (1) | AU6653698A (fr) |
CA (1) | CA2280097A1 (fr) |
WO (1) | WO1998034624A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6287854B1 (en) | 1996-10-22 | 2001-09-11 | Imperial Cancer Research Technology Limited | Diagnosis of susceptibility to cancer and treatment thereof |
AU8479498A (en) * | 1997-07-08 | 1999-02-08 | Cold Spring Harbor Laboratory | Dual specificity phosphatase and methods of use |
US6777439B2 (en) * | 2000-05-30 | 2004-08-17 | Advanced Research & Technology Institute, Inc. | Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
WO2004074459A2 (fr) * | 2003-02-19 | 2004-09-02 | Georgetown University | Cellules deficientes en pten et utilisations de celles-ci |
CN109022461B (zh) * | 2017-06-08 | 2022-01-14 | 中山大学附属第一医院 | 一种PTEN基因的上游开放阅读框45aa-uORF核苷酸序列及其编码的多肽的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998033907A1 (fr) * | 1997-01-30 | 1998-08-06 | Board Of Regents, The University Of Texas System | Suppresseur tumoral ts10q23.3 |
-
1998
- 1998-02-06 EP EP98908523A patent/EP1023076A4/fr not_active Withdrawn
- 1998-02-06 AU AU66536/98A patent/AU6653698A/en not_active Abandoned
- 1998-02-06 WO PCT/US1998/002615 patent/WO1998034624A1/fr not_active Application Discontinuation
- 1998-02-06 CA CA002280097A patent/CA2280097A1/fr not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998033907A1 (fr) * | 1997-01-30 | 1998-08-06 | Board Of Regents, The University Of Texas System | Suppresseur tumoral ts10q23.3 |
Non-Patent Citations (6)
Title |
---|
LI D-M ET AL: "TEP1, ENCODED BY A CANDIDATE TUMOR SUPPRESSOR LOCUS, IS A NOVEL PROTEIN TYROSINE PHOSPHATASE REGULATED BY TRANSFORMING GROWTH FACTOR BETA1-", CANCER RESEARCH, vol. 57, 1 June 1997 (1997-06-01), pages 2124 - 2129, XP002066157, ISSN: 0008-5472 * |
LIAW DANNY ET AL: "Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.", NATURE GENETICS, vol. 16, no. 1, 16 May 1997 (1997-05-16), pages 64 - 67, XP001024445, ISSN: 1061-4036 * |
LO SU HAO ET AL: "Molecular cloning of chick cardiac muscle tensin: Full-length cDNA sequence, expression, and characterization.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 269, no. 35, 1994, pages 22310 - 22319, XP002178161, ISSN: 0021-9258 * |
MYERS ET AL: "P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatse", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 94, 1 August 1997 (1997-08-01), pages 9052 - 9057, XP002088258, ISSN: 0027-8424 * |
NELEN M R ET AL: "Localization of the gene for Cowden disease to chromosome 10q22-23.", NATURE GENETICS, vol. 13, no. 1, 1996, pages 114 - 116, XP001024519, ISSN: 1061-4036 * |
See also references of WO9834624A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1998034624A1 (fr) | 1998-08-13 |
EP1023076A1 (fr) | 2000-08-02 |
CA2280097A1 (fr) | 1998-08-13 |
AU6653698A (en) | 1998-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9903841D0 (en) | Diagnosis and treatment of cancer | |
HUP9902068A3 (en) | Methods and compositions for the diagnosis and treatment of cancer | |
EP0831904A4 (fr) | Traitement et diagnostic du cancer de la prostate | |
ZA979096B (en) | Viral and cancer treatment | |
HUP0201757A3 (en) | Compositoins and methods for the therapy and diagnosis of lung cancer | |
IL129351A0 (en) | Hiv and cancer treatment | |
HUP0004326A3 (en) | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms | |
HK1020259A1 (en) | Composition for use in the treatment and prevention of hyperuricemia. | |
IL132287A0 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
ZA975288B (en) | The use of TCET in the prophylaxis and treatment of allergies. | |
GB9811598D0 (en) | Diagnosis and treatment of cancer | |
HK1063004A1 (en) | Oxalatoplatin and 5-fluorouracil for combination therapy of cancer | |
IL127739A0 (en) | Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases | |
EP1023076A4 (fr) | Utilisation du gene suppresseur de tumeur p-ten dans le diagnostic et le traitement de cancer | |
EP0733365A3 (fr) | Utilisation des benzoquinolin-3-ones pour le traitement et la prévention du cancer de prostate | |
AU2002346049A1 (en) | Coactivators in the diagnosis and treatment of breast cancer | |
IL127350A0 (en) | Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV | |
AU5871898A (en) | Microparticles and their use in cancer treatment | |
AU2351699A (en) | The human calcium-sensing receptor in the detection and treatment of cancer | |
EP1001966A4 (fr) | Gene de senescence et son utilisation dans le traitement du cancer et d'autres maladies | |
GB9421223D0 (en) | Tissue imaging in gene therapy | |
AU3061199A (en) | Skin treatment compositions and the use thereof | |
GB9828564D0 (en) | Materials and methods for the treatment and diagnosis of cancer | |
IL136210A0 (en) | Reagent for tumor therapy and/or imaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19990831 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20011009 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20030210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030821 |